Research output per year
Research output per year
Personal profile
Biography
Dr Daniella Brasacchio is a Research Fellow in the Blood Cancer Therapeutics laboratory and Blood Cancer Biomarkers laboratory within the School of Clinical Sciences. The laboratories focus on translational work incorporating epigenetic drugs with immunotherapy in haematological cancers, particularly lymphoma and multiple myeloma. And, research into blood based molecular biomarkers to understand normal and malignant heamatopoiesis. This research aims to translate novel biomarker discoveries to facilitate bench-to-bedside research in order to progress these new treatments into the haematology clinic.
Research interests
Blood Cancers
Cell Biology
Cancer
Epigenetics
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
PhD, PhD, Transcriptional regulation of NFkB in type 1 diabetes mellitus, Monash University
12 Jun 2004 → 11 Dec 2007
Award Date: 11 Dec 2007
Science, Bachelor, Honours, Pyridoxamine, an advanced glycation end-‐product inhibitor in the diabetic apolipoprotein E knock-‐out mouse., MONASH UNIVERSITY
1 Mar 1999 → 20 Dec 2004
Award Date: 1 Dec 2004
External positions
Research Fellow, Peter MacCallum Cancer Centre
1 Sept 2009 → 10 Oct 2015
Project Manager, Centre of Cardiovascular Research and Education in Therapeutics, Monash University
4 Jan 2009 → 25 Aug 2009
Research Fellow, Baker Heart and Diabetes Institute
1 Jan 2008 → 20 Dec 2008
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Molecular associations of response to the new-generation BTK inhibitor zanubrutinib in marginal zone lymphoma
Tatarczuch, M., Waltham, M. C., Shortt, J., Polekhina, G., Hawkes, E. A., Ho, S. J., Trotman, J., Brasacchio, D., Co, M., Li, J., Ramakrishnan, V., Dunne, K., Opat, S. S., Gregory, G. P. & on behalf of the Australasian Leukaemia and Lymphoma Group (ALLG), 25 Jul 2023, In: Blood Advances. 7, 14, p. 3531-3539 9 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access12 Citations (Scopus) -
Rationally designed chimeric PI3K-BET bromodomain inhibitors elicit curative responses in MYC-driven lymphoma
Oh, D. H., Ma, X., Hogg, S. J., He, J., Kearney, C., Brasacchio, D., Susanto, O., Maher, B., Jennings, I. G., Newbold, A., Fraser, P., Gruber, E., Kats, L. M., Gregory, G. P., Johnstone, R. W., Thompson, P. E. & Shortt, J., 5 Sept 2023, In: Proceedings of the National Academy of Sciences of the United States of America. 120, 36, 9 p., e2306414120.Research output: Contribution to journal › Article › Research › peer-review
Open Access2 Citations (Scopus) -
ALLG Laboratory Science Study LS21: Molecular Correlates of Response in Relapsed/Refractory Marginal Zone Lymphoma Patients Treated with Zanubrutinib in the MAGNOLIA Trial
Tatarczuch, M., Waltham, M. C., Shortt, J., Hawkes, E. A., Ho, S. J., Trotman, J., Brasacchio, D., Co, M., Li, J., Ramakrishnan, V., Dunne, K., Opat, S. S. & Gregory, G. P., 2022.Research output: Contribution to conference › Poster › peer-review
Open Access -
Australasian Leukaemia and Lymphoma Group (ALLG) Laboratory Science Study LS21: Molecular Correlates of Response in Relapsed/Refractory Marginal Zone Lymphoma (rrMZL) Patients Treated with Zanubrutinib in the MAGNOLIA Trial
Tatarczuch, M., Waltham, M. C., Shortt, J., Polekhina, G., Hawkes, E. A., Ho, S. J., Trotman, J., Brasacchio, D., Co, M., Li, J., Ramakrishnan, V., Dunne, K., Opat, S. S. & Gregory, G. P., 2022, p. 99. 1 p.Research output: Contribution to conference › Abstract › peer-review
Open Access -
Integrated clinical and genomic evaluation of guadecitabine (SGI-110) in peripheral T-cell lymphoma
Wong, J., Gruber, E., Maher, B., Waltham, M., Sabouri-Thompson, Z., Jong, I., Luong, Q., Levy, S., Kumar, B., Brasacchio, D., Jia, W., So, J., Skinner, H., Lewis, A., Hogg, S. J., Vervoort, S., DiCorleto, C., Uhe, M., Gamgee, J., Opat, S., & 8 others, Jun 2022, In: Leukemia. 36, 6, p. 1654–1665 12 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access14 Citations (Scopus)